ATAKE KIYOKAZU 阿竹聖和

Researcher Number	80721761
Affiliation *help	2015 – 2018 : 産業医科大学, 医学部, 助教 2014 : 産業医科大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Psychiatric science Except Principal Investigator Psychiatric science
Keywords	Principal Investigator うつ病 / RCT / 抗うつ薬 / 精神薬理学 / 治療反応予測 / 抗うつ治療 Except Principal Investigator 無作為割付比較試験 / うつ病 / 混合性の特徴 / 遺伝子多型 … More

バイオマーカーに基づく無作為割付比較試験による混合性うつ病の治療アルゴリズム構築Ongoing
- Principal Investigator
  
  加藤正樹
- Project Period (FY)
  2015 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Psychiatric science
- Research Institution
  Kansai Medical University
Prediction of response to antidepressant for patients with MDDPrincipal Investigator
- Principal Investigator
  
  ATAKE KIYOKAZU
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Psychiatric science
- Research Institution
  University of Occupational and Environmental Health, Japan

All 2016

All Journal Article Presentation

[Journal Article] Blood Biological Markers for Prediction of Escitalopram Response in Patients with Major Depressive Disorder: Preliminary Study2016
- Author(s)
  Yamana M, Atake K, Katsuki A, Hori H, Yoshimura R
- Journal Title
  
  Journal of Depression & Anxiety
  
  Volume : 5 Pages : 222-222
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26860953
[Presentation] Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) can be a prediction marker of response to escitalopram treatment in Japanese major depressive disorder patients: Preliminary data2016
- Author(s)
  Kiyokazu Atake, Masato Yamana, Ryohei Igata, Hikaru Hori, Asuka Katsuki, Yuki Konishi and Reiji Yoshimura
- Organizer
  29th ECNP Congress - Vienna 2016
- Place of Presentation
  オーストリア　ウィーン
- Year and Date
  2016-09-17
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26860953
[Presentation] 日本人大うつ病性障害患者に対するescitalopram投与による血中バイオマーカーの推移2016
- Author(s)
  阿竹聖和、山名正人、太田圭祐、中根真吾、別府拓紀、富永裕崇、井形亮平、香月あすか、堀輝、吉村玲児
- Organizer
  第26回日本臨床精神神経薬理学会
- Place of Presentation
  ホルトホール大分（大分県・大分市）
- Year and Date
  2016-11-17
- Data Source
  KAKENHI-PROJECT-26860953
[Presentation] Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) can be a prediction marker of response to escitalopram treatment in Japanese major depressive disorder patients: Preliminary data.2016
- Author(s)
  Kiyokazu Atake, Masato Yamana, Ryohei Igata, Hikaru Hori, Asuka Katsuki, Yuki Konishi and Reiji Yoshimura
- Organizer
  29th European College of Neuropsychopharmacology Congress
- Place of Presentation
  Vienna, Austria
- Year and Date
  2016-09-17
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26860953

1. 堀輝 (50421334)

# of Collaborated Projects : 2results

# of Collaborated Products : 4results
2. 吉村玲児 (90248568)

# of Collaborated Projects : 2results

# of Collaborated Products : 4results
3. 加藤正樹 (00351510)

# of Collaborated Projects : 1results

# of Collaborated Products : 0results
4. 西田圭一郎 (40567567)

# of Collaborated Projects : 1results

# of Collaborated Products : 0results
5. KATSUKI Asuka

# of Collaborated Projects : 1results

# of Collaborated Products : 4results
6. IGATA Ryohei

# of Collaborated Projects : 1results

# of Collaborated Products : 3results
7. KONISHI Yuki

# of Collaborated Projects : 1results

# of Collaborated Products : 2results

ATAKE KIYOKAZU 阿竹聖和

Research Projects

Research Products

Co-Researchers

バイオマーカーに基づく無作為割付比較試験による混合性うつ病の治療アルゴリズム構築Ongoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Prediction of response to antidepressant for patients with MDDPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Blood Biological Markers for Prediction of Escitalopram Response in Patients with Major Depressive Disorder: Preliminary Study2016

Author(s)

Journal Title

Data Source

[Presentation] Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) can be a prediction marker of response to escitalopram treatment in Japanese major depressive disorder patients: Preliminary data2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 日本人大うつ病性障害患者に対するescitalopram投与による血中バイオマーカーの推移2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) can be a prediction marker of response to escitalopram treatment in Japanese major depressive disorder patients: Preliminary data.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

ATAKE KIYOKAZU 阿竹 聖和

Research Projects

Research Products

Co-Researchers

バイオマーカーに基づく無作為割付比較試験による混合性うつ病の治療アルゴリズム構築Ongoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Prediction of response to antidepressant for patients with MDDPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Blood Biological Markers for Prediction of Escitalopram Response in Patients with Major Depressive Disorder: Preliminary Study2016

Author(s)

Journal Title

Data Source

[Presentation] Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) can be a prediction marker of response to escitalopram treatment in Japanese major depressive disorder patients: Preliminary data2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 日本人大うつ病性障害患者に対するescitalopram投与による血中バイオマーカーの推移2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) can be a prediction marker of response to escitalopram treatment in Japanese major depressive disorder patients: Preliminary data.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

ATAKE KIYOKAZU 阿竹聖和